Large Cap Biotech Analyst Fye and Major & Specialty Pharmaceuticals Analyst Schott discuss the viewpoint on Pfizer’s acquisition of Seagen on an Analyst/Industry conference call to be held on March 14 at 1 pm. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PFE:
- Seagen price target raised to $229 from $155 at RBC Capital
- Seagen price target raised to $229 from $141 at SVB Securities
- Seagen price target raised to $229 from $210 at Oppenheimer
- Seagen price target raised to $228 from $145 at Barclays
- Seagen downgraded to Market Perform from Outperform at JMP Securities